Trademark: 90818079
Word
DEMMUNIZATION
Status
Dead
Status Code
602
Status Date
Tuesday, October 18, 2022
Serial Number
90818079
Mark Type
4000
Filing Date
Thursday, July 8, 2021
Abandoned Date
Friday, October 7, 2022

Trademark Owner History

Classifications
5 Pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases and disorders; Pharmaceutical preparations and substances for the treatment of autoimmune, allergic and inflammatory diseases by eliminating specific lymphocytes lineages or modulating the immune response using a variety of organic compounds and recombinant proteins; Pharmaceutical preparations and substances that modulate the immune system by recombinant proteins that contain a targeting moiety and an effector moiety to eliminate specific lymphocytes lineages and attenuate or block the antibody creation and antigen specific immune response in autoimmune, Allergic and inflammatory diseases; Pharmaceutical preparations and substances that modulate the immune system by recombinant proteins that contain a targeting moiety and an effector moiety to eliminate specific lymphocytes lineages and attenuate or block the creation of the antibodies IgG, IgE or IgA and antigen specific immune response in autoimmune, allergic and inflammatory diseases; Pharmaceutical preparations and substances with potential immunomodulation activity to treat under and over responsiveness of the immune system

Trademark Events
Oct 18, 2022
Abandonment Notice E-Mailed - Failure To Respond
Oct 18, 2022
Abandonment - Failure To Respond Or Late Response
Apr 6, 2022
Notification Of Non-Final Action E-Mailed
Apr 6, 2022
Non-Final Action E-Mailed
Apr 6, 2022
Non-Final Action Written
Mar 28, 2022
Assigned To Examiner
Sep 15, 2021
New Application Office Supplied Data Entered In Tram
Jul 12, 2021
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24